Wednesday, June 24, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 909 of 1,261
  1. US 8252574

    Pseudoinfectious flavivirus and uses thereof

    The Board of Regents of the University of Texas System · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  2. US 8252538

    MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  3. US 8252267

    DKKL-1 splice product modulators for cancer diagnosis and therapy

    Sagres Discovery, Inc. · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  4. US 8252291

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  5. US 8251941

    Selective cytopheresis devices and related methods thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  6. US 8252280

    MAPC generation of muscle

    Regents of the University of Minnesota · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  7. US 8252275

    Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates

    Nektar Therapeutics · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  8. US 8252923

    Peptidomimetic protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  9. US 8252836

    Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease

    The Board of Regents of the University of Texas System · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  10. US 8252937

    1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones

    Addex Pharma, S.A. · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  11. US 8252933

    2-oxo-1,2-dihydro-quinoline modulators of immune function

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  12. US 8252926

    Process for the preparation of imatinib base

    Mustafa Nevzat llaç Sanayii A.S. · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  13. US 8246969

    Compositions containing aromatic aldehydes and their use in treatments

    SkinMedica, Inc. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  14. US 8247443

    Small molecule antagonists of bacterial quorum-sensing receptors

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  15. US 8247598

    Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

    Nektar Therapeutics · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  16. US 8247564

    Compounds having BETA2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  17. US 8247532

    Deuterated hepatitis C protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  18. US 8247563

    Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors

    REVIVA PHARMACEUTICALS, INC. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  19. US 8247555

    Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

    Theravance, Inc. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  20. US 8247550

    Certain substituted amides, method of making, and method of use thereof

    GILEAD CONNECTICUT, INC. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  21. US 8247536

    Factor VIII compositions

    Nektar Therapeutics · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  22. US 8247421

    5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  23. US 8247410

    Pyrimidine substituted purine derivatives

    VERASTEM, INC. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  24. US 8247420

    Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents

    REVIVA PHARMACEUTICALS, INC. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.